Full Press Release Details
CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following conferences:
RBC Capital Market Global Healthcare Conference
Wednesday May 15 at 4:05 p.m. ET. (Fireside Chat)
Link to register for the Fireside Chat can be found here
H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ
Monday May 20 at 11:30 a.m. ET. (Fireside Chat)
Link to register for the Fireside Chat can be found here
The webcast of the presentation will be accessible by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
About Fulcrum Therapeutics
LifeSci Advisors, LLC